Opendata, web and dolomites

CoroPrevention SIGNED

Personalized Prevention for Coronary Heart Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "CoroPrevention" data sheet

The following table provides information about the project.

Coordinator
TAMPEREEN KORKEAKOULUSAATIO SR 

Organization address
address: KALEVANTIE 4
city: TAMPERE
postcode: 33100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 22˙168˙724 €
 EC max contribution 19˙970˙827 € (90%)
 Programme 1. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SC1-2019-Two-Stage-RTD
 Funding Scheme IA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2026-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TAMPEREEN KORKEAKOULUSAATIO SR FI (TAMPERE) coordinator 3˙387˙774.00
2    UNIVERSITEIT HASSELT BE (HASSELT) participant 2˙447˙500.00
3    CROWN CRO OY FI (ESPOO) participant 1˙691˙172.00
4    ZORA BIOSCIENCES OY FI (ESPOO) participant 1˙249˙500.00
5    RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG DE (HEIDELBERG) participant 1˙209˙720.00
6    OULUN YLIOPISTO FI (OULU) participant 1˙196˙455.00
7    HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ FI (HELSINKI) participant 1˙115˙275.00
8    IRCCS OSPEDALE POLICLINICO SAN MARTINO IT (GENOVA) participant 942˙843.00
9    UNIWEB BE (MEISE) participant 874˙377.00
10    IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON EL (ATHINA) participant 844˙546.00
11    SOCIETE EUROPEENNE DE CARDIOLOGIE FR (BIOT SOPHIA ANTIPOLIS) participant 803˙750.00
12    SYNLAB HOLDING DEUTSCHLAND GMBH DE (AUSBURG) participant 798˙875.00
13    FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA PT (LISBOA) participant 687˙800.00
14    THE UNIVERSITY OF SHEFFIELD UK (SHEFFIELD) participant 645˙000.00
15    UNIWERSYTET JAGIELLONSKI PL (KRAKOW) participant 609˙237.00
16    LAKKA TECHNOLOGIES OY FI (LEMPAALA) participant 514˙500.00
17    CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE (BERLIN) participant 466˙250.00
18    CENTRO NACIONAL DE INVESTIGACIONESCARDIOVASCULARES CARLOS III (F.S.P.) ES (MADRID) participant 228˙750.00
19    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 153˙750.00
20    NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE UK (MANCHESTER) participant 103˙750.00

Map

 Project objective

European Coronary Heart Disease (CHD) burden is unsustainable. Better risk stratification tools and personalized care of patients are needed for reducing morbidity and mortality of CHD and the associated economic burden. To this end we have planned to shape and implement a personalized secondary prevention program for patients with established CHD. This precision strategy will be tested in a prospective trial, the CoroPrevention Trial, a central element of our proposal. We aim to significantly reduce the numbers of coronary events by using outcome risk- and patient characteristics- guided prevention in CHD patients.

1. Prospectively evaluate clinical utility of personalized prevention in CHD 2. Evaluate health economic and social benefits of the personalized prevention in CHD 3. Discover predictive markers of drug treatment response in CHD 4. Improve current ESC guidelines based on RCT validated clinical data 5. Disseminate the refined prevention program to the attention of practitioners, patients, health care payers and policy makers

This program will establish a new economically sustainable personalized treatment practice applicable throughout Europe particularly to those regions where CHD prevention needs upgrading. The used protocols and technologies will carefully assessed by NICE using their standard evaluation methods that will allow independent expert opinions for different European authorities and decision makers. These opinion statements will further be supported by full Health Economics analyses of CoroPrevention Trial.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "COROPREVENTION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "COROPREVENTION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.6.)

EULAC-PerMed (2019)

Widening EU-CELAC policy and research cooperation in Personalised Medicine

Read More  

PERMIT (2020)

PERsonalised MedicIne Trials

Read More  

GC_1000 (2020)

GROUP CARE FOR THE FIRST 1000 DAYS (GC_1000): If it takes a village to raise a child, group care is the first step

Read More